NCT01055093 Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients
| NCT ID | NCT01055093 |
| Status | Recruiting |
| Phase | — |
| Sponsor | German Diabetes Center |
| Condition | Diabetes Mellitus, Type 1 |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2005-09 |
| Primary Completion | 2030-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2005-09 with a primary completion date of 2030-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the prospective observational GDC-Study in patients with newly diagnosed diabetes mellitus aged 18-69 years at inclusion into the study is to characterize in detail the clinical, metabolical and immunological phenotype and monitor the progression of the disease and to compare the phenotype to glucose tolerant humans of similar age, body mass and sex distribution.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of diabetes mellitus according to ADA criteria * Age 18-69 * Diabetes duration since diagnosis \< 12 months * Control cohort: proven normal glucose tolerance according to ADA criteria Exclusion Criteria: * Diabetes mellitus category 3 B-H (ADA criteria) * Pregnancy * Severe renal, liver or heart disease * malignant cancer * severe psychiatric illness or addiction * participation in an intervention trial
Contact & Investigator
Michael Roden, Prof., MD
PRINCIPAL INVESTIGATOR
German Diabetes Center
Frequently Asked Questions
Who can join the NCT01055093 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 69 Years, studying Diabetes Mellitus, Type 1. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01055093 currently recruiting?
Yes, NCT01055093 is actively recruiting participants. Contact the research team at robert.wagner@ddz.de for enrollment information.
Where is the NCT01055093 trial being conducted?
This trial is being conducted at Düsseldorf, Germany.
Who is sponsoring the NCT01055093 clinical trial?
NCT01055093 is sponsored by German Diabetes Center. The principal investigator is Michael Roden, Prof., MD at German Diabetes Center. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.